Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 101 - 110 of 811 items for :

  • hormone therapy x
Clear All
Ekaterina Koledova Biopharma Global Medical Affairs, General Medicine and Endocrinology, Merck KGaA, Darmstadt, Germany

Search for other papers by Ekaterina Koledova in
Google Scholar
PubMed Close
,
George Stoyanov Biopharma Global Medical Affairs, General Medicine and Endocrinology, Merck KGaA, Darmstadt, Germany

Search for other papers by George Stoyanov in
Google Scholar
PubMed Close
,
Leroy Ovbude Business & Decision Life Sciences, Brussels, Woluwe-Saint-Lambert, Belgium

Search for other papers by Leroy Ovbude in
Google Scholar
PubMed Close
, and
Peter S W Davies Children’s Nutrition Research Centre, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia

Search for other papers by Peter S W Davies in
Google Scholar
PubMed Close

– 397 . ( https://doi.org/10.1159/000452150 ) 27884013 10.1159/000452150 3 Richmond E Rogol AD. Current indications for growth hormone therapy for children and adolescents . Endocrine Development 2010 18 92 – 108 . 20523020 10

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0172
Volume/Issue:
Volume 7: Issue 8
Open access
Bliss Anderson Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Search for other papers by Bliss Anderson in
Google Scholar
PubMed Close
and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed Close

Kramer BK Gartner R Metzner C Schofl C Berking C Hypophysitis caused by ipilimumab in cancer patients: hormone replacement or immunosuppressive therapy . Experimental and Clinical Endocrinology and Diabetes 2013 121 581 – 587 . ( https

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0489
Volume/Issue:
Volume 10: Issue 3
Open access
Paul-Martin Holterhus Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Paul-Martin Holterhus in
Google Scholar
PubMed Close
,
Alexandra Kulle Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Alexandra Kulle in
Google Scholar
PubMed Close
,
Anne-Marie Till Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Anne-Marie Till in
Google Scholar
PubMed Close
,
Caroline Stille Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Caroline Stille in
Google Scholar
PubMed Close
,
Tabea Lamprecht Department of Pediatrics I, Pediatric Endocrinology and Diabetology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian Albrechts University, CAU, Kiel, Germany

Search for other papers by Tabea Lamprecht in
Google Scholar
PubMed Close
,
Simon Vieth Department of Pediatrics I, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Kiel and Christian-Albrechts-University, CAU, Kiel, Germany

Search for other papers by Simon Vieth in
Google Scholar
PubMed Close
, and
Melchior Lauten Department of Pediatrics, Pediatric Hematology and Oncology, University Hospital of Schleswig-Holstein, UKSH, Campus Lübeck, Germany

Search for other papers by Melchior Lauten in
Google Scholar
PubMed Close

more than 1 week, others reported durations ranging from 10 to 20 weeks and even up to several months after the end of the therapy ( 4 , 5 , 6 , 7 ). Inadequate function of the hypothalamic–pituitary–adrenal axis, and hence inadequate adrenal

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0002
Volume/Issue:
Volume 12: Issue 10
Open access
Bledar Daka Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Bledar Daka in
Google Scholar
PubMed Close
,
Thord Rosen Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Thord Rosen in
Google Scholar
PubMed Close
,
Per Anders Jansson Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Per Anders Jansson in
Google Scholar
PubMed Close
,
Lennart Råstam Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Lennart Råstam in
Google Scholar
PubMed Close
,
Charlotte A Larsson Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Charlotte A Larsson in
Google Scholar
PubMed Close
, and
Ulf Lindblad Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden

Search for other papers by Ulf Lindblad in
Google Scholar
PubMed Close

. Medical history, socio-economic and lifestyle factors Standard questionnaires were used to obtain information on previous hospitalisations, current medication (including contraceptives and hormonal replacement therapy), smoking and alcohol habits as well

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-12-0057
Volume/Issue:
Volume 2: Issue 1
Open access
Nella Augusta Greggio Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Nella Augusta Greggio in
Google Scholar
PubMed Close
,
Elisa Rossi CINECA – Interuniversity Consortium (Health Service), Bologna, Italy

Search for other papers by Elisa Rossi in
Google Scholar
PubMed Close
,
Silvia Calabria CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Silvia Calabria in
Google Scholar
PubMed Close
,
Alice Meneghin Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Alice Meneghin in
Google Scholar
PubMed Close
,
Joaquin Gutierrez de Rubalcava Endocrinology and Adolescence Unit, Department of Woman and Child Health, University of Padova, Padova, Italy

Search for other papers by Joaquin Gutierrez de Rubalcava in
Google Scholar
PubMed Close
,
Carlo Piccinni CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Carlo Piccinni in
Google Scholar
PubMed Close
, and
Antonella Pedrini CORE srl – Collaborative Outcome Research, Bologna, Italy

Search for other papers by Antonella Pedrini in
Google Scholar
PubMed Close

-adolescents, 0–13 years. The only data available are referred to a population aged 13–16 years ( 45 ). Specifically, we identified the paediatric population with SH that has been treated with hormone replacement therapy. In fact, since SH is often asymptomatic

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0066
Volume/Issue:
Volume 6: Issue 6
Open access
Xiaoya Zheng Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Xiaoya Zheng in
Google Scholar
PubMed Close
,
Heng Xiao Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Heng Xiao in
Google Scholar
PubMed Close
,
Jian Long Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Jian Long in
Google Scholar
PubMed Close
,
Qiang Wei Prevention of Disease Department, Chongqing Jiulongpo District Hospital of Traditional Chinese Medicine, Chongqing, China

Search for other papers by Qiang Wei in
Google Scholar
PubMed Close
,
Liping Liu Department of Ultrasound, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Liping Liu in
Google Scholar
PubMed Close
,
Liping Zan Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Liping Zan in
Google Scholar
PubMed Close
, and
Wei Ren Department of Endocrinology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

Search for other papers by Wei Ren in
Google Scholar
PubMed Close

Introduction Programmed cell death protein-1 (PD-1) blockade therapies are widely used for the treatment of hepatocellular carcinoma (HCC) ( 1 ). In addition to their antitumor effects, anti-PD-1 antibodies have been reported to cause immune

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-22-0065
Volume/Issue:
Volume 11: Issue 5
Open access
Yanling Cai Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Yanling Cai in
Google Scholar
PubMed Close
,
Yan Yang Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Yan Yang in
Google Scholar
PubMed Close
,
Xiao Pang Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Xiao Pang in
Google Scholar
PubMed Close
, and
Suping Li Department of Nuclear Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China

Search for other papers by Suping Li in
Google Scholar
PubMed Close

. TC among male patients tends to be more aggressive at the time of diagnosis and may be associated with a poor prognosis ( 1 , 2 ). This implies a higher TC risk stratification in men. Radioactive iodine therapy (RAI or 131 I therapy) is the main

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-23-0299
Volume/Issue:
Volume 12: Issue 12
Open access
Michael Ulm University of Tennessee Health Science Center, Memphis, Tennessee, USA
West Cancer Center, Memphis, Tennessee, USA

Search for other papers by Michael Ulm in
Google Scholar
PubMed Close
,
Arvind V Ramesh White Station High School, Memphis, Tennessee, USA

Search for other papers by Arvind V Ramesh in
Google Scholar
PubMed Close
,
Keely M McNamara Tohoku University, Miyagi, Japan

Search for other papers by Keely M McNamara in
Google Scholar
PubMed Close
,
Suriyan Ponnusamy University of Tennessee Health Science Center, Memphis, Tennessee, USA

Search for other papers by Suriyan Ponnusamy in
Google Scholar
PubMed Close
,
Hironobu Sasano Tohoku University, Miyagi, Japan

Search for other papers by Hironobu Sasano in
Google Scholar
PubMed Close
, and
Ramesh Narayanan University of Tennessee Health Science Center, Memphis, Tennessee, USA
West Cancer Center, Memphis, Tennessee, USA

Search for other papers by Ramesh Narayanan in
Google Scholar
PubMed Close

antagonists LHRH is a major target for ADT therapy. The hypothalamus–pituitary–hypogonadal (HPG) axis is important for the synthesis of testosterone by the testes ( 11 ). The hypothalamus releases gonadotropin-releasing hormone (GnRH or LHRH) that stimulates

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-18-0425
Volume/Issue:
Volume 8: Issue 2
Open access
Robert Rapaport Division of Pediatric Endocrinology & Diabetes, Mount Sinai Kravis Children’s Hospital and Icahn School of Medicine at Mount Sinai, New York, New York, USA

Search for other papers by Robert Rapaport in
Google Scholar
PubMed Close
,
Jan M Wit Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands

Search for other papers by Jan M Wit in
Google Scholar
PubMed Close
, and
Martin O Savage Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, London, UK

Search for other papers by Martin O Savage in
Google Scholar
PubMed Close

Biller BMK Boguszewski MCS Cheung PT Choong CSY Cohen LE Cohen P et al . Diagnosis, genetics, and therapy of short stature in children: a Growth Hormone Research Society International Perspective . Hormone Research in Paediatrics 2019 92

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0585
Volume/Issue:
Volume 10: Issue 3
Open access
Régis Coutant Department of Pediatric Endocrinology and Diabetology, Reference Center for Rare Pituiatry Diseases, University Hospital of Angers, Angers, France

Search for other papers by Régis Coutant in
Google Scholar
PubMed Close
,
Maithé Tauber Reference Center for the Prader-Willi syndrome and other rare obesities with feeding disorders (PRADORT), Children Hospital, CHU Toulouse, Toulouse, France
Pediatric team of the Clinical Investigation Center 9302/INSERM, Hospital of Children, Toulouse, France
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, Toulouse, France

Search for other papers by Maithé Tauber in
Google Scholar
PubMed Close
,
Béatrice Demaret GRANDIR - French Growth Disorders Association, Asnières-sur-Seine, France

Search for other papers by Béatrice Demaret in
Google Scholar
PubMed Close
,
Robin Henocque Pfizer France, Paris France

Search for other papers by Robin Henocque in
Google Scholar
PubMed Close
,
Yves Brault Pfizer France, Paris France

Search for other papers by Yves Brault in
Google Scholar
PubMed Close
,
François Montestruc eXYSTAT, Malakoff, France

Search for other papers by François Montestruc in
Google Scholar
PubMed Close
,
Olivier Chassany Health Economics Clinical Trial Unit (URC-ECO), Hospital of Hotel-Dieu, AP-HP, Paris, France
Patient-Reported Outcomes Unit (PROQOL), UMR 1123, University Paris Cité, INSERM, Paris, France

Search for other papers by Olivier Chassany in
Google Scholar
PubMed Close
,
Michel Polak Hôpital Universitaire Necker Enfants Malades, Pediatric Endocrinology, Gynecology and Diabetology, Imagine Institute, INSERM U1163, Cochin Institute, INSERM U1016, Centre de référence des pathologies endocriniennes rares de la croissance et du développement, Université de Paris Cité, Paris, France

Search for other papers by Michel Polak in
Google Scholar
PubMed Close
, and
the QOLITHOR Study Group
Search for other papers by the QOLITHOR Study Group in
Google Scholar
PubMed Close
the QOLITHOR Study Group

insufficiency as part of multiple pituitary hormone deficiencies as well as other conditions (small for gestational age (SGA), Prader–Willi syndrome (PWS), Turner syndrome, or chronic renal failure). Pediatric patients on hormonal replacement therapy for other

Article Type:
Research Article
Collections:
Paediatric Endocrinology
DOI:
https://doi.org/10.1530/EC-22-0464
Volume/Issue:
Volume 12: Issue 4
Open access